基本信息
views: 259

Bio
Dr. Levin is studying the immune response to herpes virus infections and methods of treating and preventing such infections, including antiviral therapy and active immunization. He does basic research on the nature of latency of herpes viruses in human neurons. A vaccine to prevent shingles in elderly individuals has been developed and licensed through his clinical research, and further investigations of this vaccine are in progress.
Research Interests
Papers共 351 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Human vaccines & immunotherapeuticsno. 1 (2024): 2351675-2351675
JOURNAL OF IMMUNOLOGYno. 1 (2024)
Diseases (Basel, Switzerland)no. 12 (2024)
Myron J. Levin, Neda Al Rawashdh, Liliane Mofor,Pablo Anaya, Richard M. Zur, Emily B. Kahn, Daniel Yu,Joaquin F. Mould-Quevedo
VACCINESno. 11 (2024)
Infectious Diseases and Therapypp.1-16, (2024)
EXPERT REVIEW OF VACCINESno. 1 (2024): 124-136
Myron J. Levin,Andrew Ustianowski,Steven Thomas,Alison Templeton, Yuan,Seth Seegobin,Catherine F. Houlihan,Ibrahim Menendez-Perez,Simon Pollett,Rosalinda H. Arends,Rohini Beavon,Kanika Dey,Pedro Garbes,Elizabeth J. Kelly,Gavin C. K. W. Koh,Stefan Ivanov,Karen A. Near,Audrey Sharbaugh,Katie Streicher,Menelas N. Pangalos,Mark T. Esser
JOURNAL OF INFECTIOUS DISEASESno. 10 (2023): 1367-1374
Current topics in microbiology and immunology (2023): 223-246
Load More
Author Statistics
#Papers: 351
#Citation: 24253
H-Index: 79
G-Index: 147
Sociability: 7
Diversity: 4
Activity: 19
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn